Avantor (AVTR) Appoints Ludovic Brellier as EVP and Chief Transformation Officer
Key takeaways
- Avantor (AVTR) Appoints Ludovic Brellier as EVP and Chief Transformation Officer Maham Fatima Mon, June 1, 2026 at 6:37 PM GMT+7 2 min read AVTR DHR Avantor Inc.
- Brellier joins the company from Danaher, where he most recently served as President of Cytiva’s Hardware Solutions business.
- Benoit Gourdier, the current Executive Vice President of the BMP segment, will remain with Avantor until the end of 2026 to facilitate an orderly leadership transition.
Avantor (AVTR) Appoints Ludovic Brellier as EVP and Chief Transformation Officer Maham Fatima Mon, June 1, 2026 at 6:37 PM GMT+7 2 min read AVTR DHR Avantor Inc. (NYSE:AVTR) is one of the best cheap stocks under $10 to buy in June. On April 23, Avantor announced the appointment of Ludovic Brellier as Executive Vice President, Bioscience & Medtech Products/BMP and Chief Transformation Officer, effective May 1. In this dual role, Brellier will oversee the growth and operational performance of the BMP business while leading the company’s enterprise-wide transformation initiative, the Revival Management Office.
Brellier joins the company from Danaher, where he most recently served as President of Cytiva’s Hardware Solutions business. His previous experience includes significant leadership roles in biopharma innovation, manufacturing, and commercialization, as well as managing the integration of Pall Life Sciences into Cytiva. Avantor’s leadership noted that his background in business transformation will be essential as the company executes its broader strategic initiatives.
Benoit Gourdier, the current Executive Vice President of the BMP segment, will remain with Avantor until the end of 2026 to facilitate an orderly leadership transition. Avantor’s President and CEO, Emmanuel Ligner, expressed confidence that Brellier’s operational expertise will help maximize the potential of the company’s product brands and support long-term sustainable growth.